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Abstract
Background—Few data exist describing health care seeking behaviors among persons with 
influenza-like illness (ILI) or adherence to influenza antiviral treatment recommendations.
Methods—We analyzed adult responses to the Behavioral Risk Factor Surveillance System in 31 
states and the District of Columbia (D.C.) and pediatric responses in 25 states and D.C. for 
January – April 2011 by demographics and underlying health conditions.
Results—Among 75,088 adult and 15,649 child respondents, 8.9% and 33.9%, respectively, 
reported ILI. ILI was more frequent among adults with asthma (16%), chronic obstruction 
pulmonary disease (COPD; 26%), diabetes (12%), heart disease (19%), kidney disease (16%), or 
obesity (11%).
Forty-five percent of adults and 57% of children sought health care for ILI. Thirty-five percent of 
adults sought care ≤2 days after ILI onset. Seeking care ≤2 days was more frequent among adults 
with COPD (48%) or heart disease (55%).
Among adults with a self-reported physician diagnosis of influenza, 34% received treatment with 
antiviral medications. The only underlying health condition with a higher rate of treatment was 
diabetes (46%).
Conclusion—Adults with underlying health conditions were more likely to report ILI, but the 
majority did not seek care promptly, missing opportunities for early influenza antiviral treatment.
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Introduction
The Advisory Committee on Immunization Practices (ACIP) recommends early, empiric 
treatment of influenza with antiviral medications for persons at high risk for influenza 
complications, including adults aged ≥65 years, and persons with chronic pulmonary or 
cardiovascular conditions, and diabetes[1]. In the United States, there are few data 
describing clinician adherence to ACIP recommendations or the tendency for persons with 
influenza-like illness (ILI) to seek healthcare promptly after illness onset [1–3]. The few 
studies that have described adherence to ACIP treatment recommendations in an outpatient 
setting suggest that adherence could be improved [4, 5].
To assess whether ACIP treatment guidelines were followed during the 2009 influenza 
pandemic, the Centers for Disease Control and Prevention (CDC) utilized a community-
based telephone survey among the U.S. population [6, 7]. Results indicated that during the 
2009 pandemic, most persons at high risk for influenza complications more frequently 
reported ILI and healthcare seeking but did not report increased receipt of influenza antiviral 
medication. The results also indicated that certain socioeconomic and healthcare access 
factors (e.g. unemployment, lack of insurance, financial barriers to healthcare) may have 
reduced access to appropriate medical treatment [6, 7].
The 2009 pandemic was associated with frequent communications reminding those with 
high-risk factors to seek healthcare promptly and for healthcare providers to treat them with 
influenza antivirals. Additionally, ACIP treatment guidelines were updated prior to the start 
of the 2010–11 influenza season and included the addition of morbid obesity as a risk factor 
for severe influenza illness for the first time [1]. Therefore, CDC repeated the telephone 
survey during the 2010–2011 influenza season to determine if the previous findings would 
be consistent during a seasonal influenza epidemic and to assess the time to seek healthcare, 
which was not collected in the previous survey [3]. In this report, we present the results from 
this survey conducted from January 2011 to April 2011 among adult respondents in 31 states 
and the District of Columbia (DC) and pediatric respondents in 25 states and DC.
Methods
The Behavioral Risk Factor Surveillance System (BRFSS) is a state-based, random-digit-
dialed telephone survey that is the main data source for information on the prevalence of 
health-risk behaviors and chronic health conditions among the non-institutionalized U.S. 
population aged ≥18 years [8]; survey methodology is described elsewhere [9]. The BRFSS 
has been approved as exempt research by the CDC’s institutional review board.
From January 1, 2011 to April 30, 2011, adult respondents in 31 states1 and DC were 
interviewed using a BRFSS ILI module that contained questions to determine recent ILI and 
healthcare-seeking behavior. Among adults who sought care, additional questions were 
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asked to determine the time to seek care, whether an influenza diagnosis was received, 
whether influenza testing was performed, and whether influenza antiviral treatments were 
prescribed. We determined the presence of ILI by asking 2 questions: “Last month, were 
you ill with a fever?” and “Did you also have a cough and/or sore throat?” Answering “yes” 
to both questions was classified as ILI. We determined whether medical care was sought by 
asking, “Did you visit a doctor, nurse, or other health professional for this illness?” and 
when medical care was sought by asking, “When did you visit the doctor, nurse, or other 
health professional for this illness?” and giving a choice of 3 responses: (1) “Within 2 days 
of getting ill,” (2) “Within 3 to 7 days of getting ill,” or (3) “More than 7 days of getting ill.” 
Seeking care within 2 days of getting ill was chosen as the endpoint for prompt care seeking 
because that is when influenza antivirals have shown the most benefit and because this time 
point serves as the cut-off for approved administration of influenza antivirals in the product 
license [1, 10]. We determined whether a clinical diagnosis of influenza was given by 
asking, “What did the doctor, nurse, or other health professional tell you?” and giving a 
choice of 2 responses: (1) “You had influenza or the flu” or (2) “You had some other illness, 
but not the flu.” We determined whether an influenza test was given by asking, “Did you 
have a flu test that was positive for this illness?” and giving a choice of 3 responses: (1) 
“Had flu test and it was positive,” (2) “Had flu test and it was negative,” or (3) “Did not 
have flu test.” Finally, we determined whether antiviral medications were given by asking, 
“Did you receive Tamiflu® or oseltamivir or an inhaled medicine called Relenza® or 
zanamivir to treat this illness?”
We determined the presence of ILI and healthcare seeking among children in 25 states2 and 
DC by asking adult respondents about their child’s illness. The time to seek care, the clinical 
diagnosis, and receipt of an influenza test or influenza antiviral medication treatment were 
not ascertained for children.
Adult respondents were evaluated by demographic characteristics, pre-existing health 
conditions, pregnancy, behavioral factors, and healthcare access. Demographic 
characteristics evaluated were age, sex, race or ethnicity, educational attainment, and 
employment status. Pre-existing health-conditions evaluated were asthma, chronic 
obstructive pulmonary disorder (COPD), diabetes, heart disease (ever having been 
diagnosed with myocardial infarction; angina; or chronic-heart disease), kidney disease, 
arthritis, depression, disability, and WHO BMI classification as calculated from self-
reported weight and height. The only behavioral factor evaluated was smoking. Health-care 
access questions evaluated were insurance status among those 18–64 years old, having a 
personal doctor(s), and healthcare affordability. The characteristics of children with ILI and 
healthcare seeking were evaluated by age, sex, and race or ethnicity.
1States or territories using the BRFSS ILI module were Alabama, Alaska, Arizona, California, Colorado, Connecticut, Delaware, 
Georgia, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana, 
Nebraska, New Hampshire, New Jersey, North Carolina, Oklahoma, Oregon, Rhode Island, South Dakota, Utah, Virginia, and 
Wisconsin.
2States using the BRFSS ILI module for children were Alabama, Arizona, California, Connecticut, Delaware, Georgia, Illinois, Iowa, 
Kansas, Louisiana, Maryland, Massachusetts, Mississippi, Missouri, Montana, Nebraska, New Hampshire, New Jersey, North 
Carolina, Oklahoma, Oregon, Rhode Island, South Dakota, Utah, Virginia
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We used SAS-callable SUDAAN® v.10 statistical software (Research Triangle Institute, 
NC) to calculate population-weighted estimates and corresponding standard errors, 95% 
confidence intervals (CIs), and p values, taking into account the design of the BRFSS 
sampling plan. We used linear contrasts to evaluate differences in responses by age group, 
sex, race-ethnic categories, pre-existing health conditions, behavioral factors, and health-
care access questions. Statistical significance was set at alpha (α) ≤0.05. Because the age 
and sex distributions among groups differed, prevalence estimates were age-adjusted using 
the standard year 2000 projected U.S. population10.
Response rates were calculated using Council of American Survey and Research 
Organizations guidelines [9]. Median survey response rates were calculated as the 
percentage of people who completed interviews among all eligible people, including those 
who were not contacted, while median cooperation rates were calculated as the percentage 
of people who completed interviews among all eligible people who were contacted.
Results
Report of ILI among adults and children
From January 2011 to April 2011, a total of 75,088 adults and 15,649 children were 
interviewed using the BRFSS ILI module. The median state survey response rate was 53% 
(range=37%–66%), and the median cooperation rate was 77% (range=55%–89%).
During this period, 8.9% of adults (median age = 41 years) reported ILI in the calendar 
month preceding interview (Table 1). ILI was more frequently reported among adults who 
were American Indian/Alaska Native (20%), unemployed (11%), or unable to work (15%), 
or who reported current (16%) or former (14%) asthma, COPD (26%), diabetes (12%), heart 
disease (19%), kidney disease (16%), depression (16%), disability (14%), obesity (11%), or 
financial barriers to care (15%) (Tables 1 and 2).
During this same period, 33.9% of children were reported to have ILI (median age = 7 
years); children who were in the age groups 0–4 years old (38%) or 5–11 years old (37%) 
were reported to have ILI more frequently, while children who were identified as black, NH 
were reported to have ILI less frequently (27%) (Table 3).
Report of health care seeking among adults and children
Among those participants who reported ILI, 45% of adults reported seeking health care 
(Table 1). Healthcare seeking was significantly more frequent among adults who were ≥65 
years old (60%); who reported COPD (62%); heart disease (59%); kidney disease (69%); 
disability (50%); being obese (52%); or having current (57%) or past (58%) asthma (Tables 
1 and 2). Conversely, reports of healthcare seeking were significantly less frequent among 
adults who identified as AI/AN (34%), were unemployed (35%), or who reported having no 
insurance (27%) or no personal doctor (38%) (Tables 1 and 2).
Among children with ILI, 57% were reported to have sought health care, and children in the 
age groups 0–4 years old (68%) and 5–11 years old (56%) and those who were black, NH 
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(67%); or Hispanic (64%) were reported to have sought care significantly more frequently 
(Table 3).
Time to seek health care among adults
Of adult health care seekers, 35% sought care for ILI within 2 days and 47% within 3–7 
days of illness onset (Table 4). Among the medical conditions evaluated, only adults with 
COPD (48%) or heart disease (55%) were significantly more likely to seek care within 2 
days (Table 5). Adults who were unemployed (25%), unable to work (27%), or who reported 
diabetes (23%), kidney disease (22%), or no insurance (23%) were significantly less likely 
to seek care within 2 days (Tables 4 and 5).
Report of influenza diagnosis and influenza testing among adults
Among adults who reported ILI and sought health care, 26% reported a clinical diagnosis of 
influenza, and 27% reported receiving an influenza test. Reports of receiving a clinical 
diagnosis of influenza (19%) or an influenza diagnostic test (11%) were less frequent among 
adults who sought health care ≥7 days from illness onset (Supplemental Tables 1&2).
Antiviral medication receipt among adults diagnosed with influenza
Among adults who reported ILI, sought health care, and were diagnosed with influenza, 
34% reported receiving an influenza antiviral medication (Table 1). Influenza antiviral 
medication receipt did not significantly differ by most of the characteristics evaluated with 
sufficient numbers for reliable estimates, including most high-risk conditions in adults 
(Tables 1 and 2). Receipt of influenza antiviral medication was significantly higher among 
persons with diabetes (46%) but was significantly lower among adults who were disabled 
(18%) (Tables 1 and 2). Patients who sought care within 2 days (55%) were significantly 
more likely to have reported receiving influenza antiviral medication than those who sought 
care later (35%) (Table 5).
Discussion
To our knowledge, this study represents the largest telephone survey conducted in the 
United States that describes health care seeking and outpatient use of antiviral medications 
among adults with high-risk conditions during a regular influenza season. We found that 
most adults with underlying medical conditions had higher proportions of self-reported ILI 
but were not more likely to seek care within two days, except those with COPD and heart 
disease, or to be treated with influenza antiviral medications. However, we found that 
prompt health care seeking was associated with increased receipt of antiviral medications. 
Our findings highlight the need to educate patients at high risk for influenza complications 
to seek care early, to educate physicians about the benefits of influenza antiviral treatment 
among high risk patients, and to better understand the social, medical and economic barriers 
that may prevent use of influenza antiviral treatment that is consistent with ACIP 
recommendations during a seasonal influenza epidemic.
During the 2010–11 influenza season, AI/AN adults and those reporting asthma, heart 
disease, and disability were more likely to report ILI, a finding consistent with risk factors 
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for ILI identified during the 2009 pandemic [6, 7]. Additionally, adults reporting COPD, 
kidney disease, arthritis, and depression, conditions that were not ascertained during the 
previous BRFSS pandemic survey, were also more likely to report ILI. The consistency of 
these results may indicate that certain ACIP high-risk conditions, which are already known 
to confer an increased risk for influenza complications, may also increase the risk for the 
acquisition of influenza or other respiratory virus infections [11–16]. Alternately, persons 
with high-risk conditions in this study may have just been more likely to recall symptoms 
consistent with influenza illness. No study has systematically assessed the risk for acquiring 
influenza by the presence or absence of ACIP high-risk conditions, and further research is 
needed before any assessment of differential risk can be made.
Only a third of respondents sought care within 2 days of illness onset, when influenza 
antiviral medications are most effective, and prompt health care seeking was associated with 
increased receipt of antiviral medications in this survey. However, more than 80% of 
patients sought care within 7 days when antivirals may have some benefit [1, 17, 18]. Those 
without insurance and those who are unemployed or unable to work were significantly more 
likely to either delay care or not seek care, which may place them at higher risk for severe 
outcomes from influenza. Efforts to identify and reduce the barriers associated with missed 
or delayed healthcare seeking among the unemployed and those unable to work or without 
health insurance are needed to ensure that access to effective antiviral treatment is available 
to this population.
Thirty-four percent of respondents who received an influenza diagnosis reported receiving 
an influenza antiviral medication. This represents a large increase from the 14%–19% that 
reported receiving an influenza antiviral medication during the 2006–07 influenza season 
and is similar to the 36% reported during the 2009 pandemic [6, 19]. The reason for this 
increase is unclear but may be the result of expansion of ACIP recommendations for 
influenza antiviral treatment from 2008 [20] to the 2009 pandemic [21] or an increasing 
number of publications and communications describing the benefits of early empiric 
treatment with influenza antiviral medications, especially during and after the 2009 
pandemic. However, challenges in increasing the uptake of influenza antiviral medications 
remain. This study found that groups at increased risk for severe illness (most persons 
reporting any chronic condition and those ≥65 years) have similar or lower rates of antiviral 
medication receipt when compared to younger persons or persons with no ACIP high-risk 
conditions. These results are similar to those seen during the 2009 pandemic and the 2006–
07 influenza season and suggest that more work is needed to improve treatment rates among 
those most vulnerable to influenza complications. This should include efforts to better 
understand the effect of reduced healthcare access and affordability on receipt of appropriate 
and timely influenza antiviral treatment as well as the impact that a lack of physician 
education may have.
Our results also reinforce the finding that telephone surveys, which traditionally have not 
been used to monitor morbidity from influenza, may provide an efficient survey method for 
monitoring the burden of disease from influenza and adherence to treatment guidelines. As 
such, they may also help better define the assumptions of mathematical models describing 
the transmission and spread of influenza. Because data describing differences in healthcare 
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seeking, time to seek healthcare, and antiviral treatment by demographic groups have been 
largely unavailable, mathematical models frequently utilized assumptions that may not have 
been validated with epidemiological or laboratory data from seasonal or pandemic influenza 
[22]. The results of this study, including the important behavioral information, may help 
provide some of this missing information.
The methodology in this report is subject to several limitations. First, the positive predictive 
value of the ILI definition used in this study likely varied over time as the prevalence of 
influenza illness fluctuated throughout the influenza season [6, 7]. This may have caused 
respondents to self-report ILI that was not influenza, particularly during periods of low 
influenza activity. Second, data in this study are self-reported and subject to recall and social 
desirability bias. Therefore, the report of a clinical diagnosis of influenza or receiving an 
influenza diagnostic test or antiviral medication has not been verified and may represent the 
receipt of diagnoses other than influenza or non-influenza clinical tests or treatments (e.g., 
antibiotics). However, we would expect any potential misclassification to be similar for 
high-risk and non-high risk respondents. Third, because the percentage of respondents 
reporting a positive influenza test can be influenced by the duration from illness onset to 
health care encounter and the sensitivity of the type of influenza diagnostic test used, the 
proportion of respondents reporting a positive influenza test should not be interpreted as the 
percentage of confirmed influenza [23–25]. Fourth, we only assessed risk factors available 
in the BRFSS during the 2010–11 influenza season. Therefore, because some known risk 
factors for influenza complications were not included (e.g., persons with hepatic, neurologic/
neuromuscular, or hematologic disorders or persons with immunosuppression), some 
persons with high-risk conditions could be misclassified as having no high-risk medical 
conditions. Fifth, BRFSS data are collected only from households with a landline telephone, 
and our study is subject to selection bias resulting from exclusion of households with only 
cellular phones [26]. Finally, the BRFSS is a household survey that does not collect 
information from persons in institutions, nursing homes, long-term-care facilities, and 
correctional institutions. Therefore, the results presented in this analysis do not generalize to 
these populations.
During the influenza season following the 2009 pandemic, most adults with underlying 
medical conditions had higher proportions of self-reported ILI but were not more likely to 
seek healthcare promptly than individuals without these conditions. A third of persons who 
received a diagnosis of influenza during a medical visit reported receiving treatment with 
antiviral medication, and the rates of antiviral treatment were not significantly different 
among those with and without any high risk condition. Further efforts are needed to educate 
persons at high risk to seek healthcare early and to identify reasons why persons at high risk 
are not receiving influenza antivirals.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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